582 related articles for article (PubMed ID: 3232527)
41. Differential inhibition of neuropeptide Y on the chronotropic and inotropic responses to sympathetic and parasympathetic stimulation in the isolated, perfused dog atrium.
Ren LM; Furukawa Y; Karasawa Y; Murakami M; Takei M; Narita M; Chiba S
J Pharmacol Exp Ther; 1991 Oct; 259(1):38-43. PubMed ID: 1920125
[TBL] [Abstract][Full Text] [Related]
42. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
Franco-Cereceda A; Matran R; Alving K; Lundberg JM
Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
[TBL] [Abstract][Full Text] [Related]
43. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
[TBL] [Abstract][Full Text] [Related]
45. Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release.
Pernow J; Schwieler J; Kahan T; Hjemdahl P; Oberle J; Wallin BG; Lundberg JM
Am J Physiol; 1989 Sep; 257(3 Pt 2):H866-72. PubMed ID: 2782443
[TBL] [Abstract][Full Text] [Related]
46. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
[TBL] [Abstract][Full Text] [Related]
48. Adrenergic and non-adrenergic vasoconstrictor mechanisms in the human nasal mucosa.
Fischer L; Auberson S; Bretton C; Lacroix JS
Rhinology; 1993 Mar; 31(1):11-5. PubMed ID: 8100640
[TBL] [Abstract][Full Text] [Related]
49. Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa.
Lundblad L; Anggard A; Saria A; Lundberg JM
J Auton Nerv Syst; 1987 Oct; 20(3):189-97. PubMed ID: 3693801
[TBL] [Abstract][Full Text] [Related]
50. Sympathetic neuromuscular transmission in rat tail artery: a study based on electrochemical, electrophysiological and mechanical recording.
Bao JX
Acta Physiol Scand Suppl; 1993; 610():1-58. PubMed ID: 8397469
[TBL] [Abstract][Full Text] [Related]
51. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation.
Weitzberg E
Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340
[TBL] [Abstract][Full Text] [Related]
52. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilatation and protein extravasation.
Martling CR
Acta Physiol Scand Suppl; 1987; 563():1-57. PubMed ID: 3499054
[TBL] [Abstract][Full Text] [Related]
53. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Franco-Cereceda A; Lundberg JM; Dahlöf C
Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig.
Franco-Cereceda A; Nagata M; Svensson TH; Lundberg JM
Eur J Pharmacol; 1987 Oct; 142(2):267-73. PubMed ID: 3691641
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.
Lundberg JM; Saria A; Franco-Cereceda A; Hökfelt T; Terenius L; Goldstein M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):331-40. PubMed ID: 2858824
[TBL] [Abstract][Full Text] [Related]
56. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
57. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
58. Reserpine-induced depletion of neuropeptide Y in the guinea-pig: tissue-specific effects and mechanisms of action.
Nagata M; Franco-Cereceda A; Saria A; Amann R; Lundberg JM
J Auton Nerv Syst; 1987 Oct; 20(3):257-63. PubMed ID: 3121715
[TBL] [Abstract][Full Text] [Related]
59. Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects.
Rudehill A; Sollevi A; Franco-Cereceda A; Lundberg JM
Peptides; 1986; 7(5):821-6. PubMed ID: 3025824
[TBL] [Abstract][Full Text] [Related]
60. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
